/TIVC
TIVC Stock - Tivic Health Systems, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.74-7.94%
$0.15 (-7.94%) • Dec 19
43
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.41
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.91
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TIVC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.72 – $1.76
TARGET (TP)$2.00
STOP LOSS$1.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.98
52W High$15.64
52W Low$1.47
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $780,000 | $1.18M | $1.84M | $1.17M | $860,000 |
| Gross Profit | $2,000 | $287,000 | $299,000 | $-129,000 | $-225,000 |
| Gross Margin | 0.3% | 24.4% | 16.3% | -11.1% | -26.2% |
| Operating Income | $-5,661,000 | $-8,245,000 | $-10,098,000 | $-5,632,000 | $-3,204,000 |
| Net Income | $-5,655,000 | $-8,244,000 | $-10,095,996 | $-8,494,000 | $-3,639,000 |
| Net Margin | -725.0% | -701.0% | -548.7% | -728.5% | -423.1% |
| EPS | $-19.67 | $-176.72 | $-104.37 | $-243.16 | $-177.01 |
Company Overview
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TIVCBeat Rate
73%
Last 11 quarters
Avg Surprise
-657.1%
EPS vs Estimate
Beats / Misses
8/3
Last 12 quarters
Latest EPS
$-1.97
Q4 2025
EPS Surprise History
Q1 24
-269.7%
$-25.88vs$-7.00
Q2 24
+85.6%
$-17.18vs$-119.00
Q3 24
+94.7%
$-5.44vs$-102.00
Q4 24
+96.2%
$-3.91vs$-102.00
Q1 25
+81.9%
$-15.42vs$-85.00
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-1.97 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-2.19 | — | — |
Q2 2025 | May 15, 2025 | — | $-2.52 | — | — |
Q1 2025 | Mar 21, 2025 | $-85.00 | $-15.42 | +81.9% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-102.00 | $-3.91 | +96.2% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-102.00 | $-5.44 | +94.7% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $-119.00 | $-17.18 | +85.6% | ✓ BEAT |
Q1 2024 | Mar 29, 2024 | $-7.00 | $-25.88 | -269.7% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-119.05 | $-25.17 | +78.9% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-136.05 | $-119.05 | +12.5% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-527.21 | $-391.16 | +25.8% | ✓ BEAT |
Q1 2023 | Mar 13, 2023 | $-0.31 | $-23.30 | -7416.1% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-544.22 | $-459.18 | +15.6% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-408.16 | $-544.22 | -33.3% | ✗ MISS |
Q2 2022 | May 16, 2022 | — | $-391.16 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-55.72 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-89.99 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-46.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-58.09 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-48.32 | — | — |
Latest News
Tivic Health Acquires Strategic Manufacturing And Development Assets Of Scorpius Holdings; Launches Velocity Bioworks Subsidiary; Secures $16M Debt, Up To $75M Preferred Equity, And $50M Credit Line from 3i, LP
📈 PositiveBenzinga•Dec 11, 2025, 02:51 PM•Also:
Tivic Health Systems Secures Techwatch Meeting With Biomedical Advanced Research and Development Authority's Radiological and Nuclear Medical Countermeasures Program Staff For for Acute Radiation Syndrome
📈 PositiveBenzinga•Nov 18, 2025, 01:35 PM
Tivic Health Systems Q3 EPS $(2.00) Up From $(3.93) YoY, Sales $146.000K Up From $126.000K YoY
📈 PositiveBenzinga•Nov 14, 2025, 09:49 PM
Tivic Health Highlights Study With Feinstein Institutes for Medical Research at Northwell Health Of Non-Invasive Cervical Vagus Nerve Stimulation, Demonstrating That Personalizing The Stimulation Parameters To Each User Enhanced Autonomic Effects
📈 PositiveBenzinga•Nov 13, 2025, 01:33 PM
Tivic Health Files New Patents For TLR5 Agonists In Advanced Cancer Therapy And Optimized Vagus Nerve Stimulation Device
📈 PositiveBenzinga•Nov 10, 2025, 02:09 PM
Tivic Health Systems Has Received A Notice Of Allowance For A U.S. Patent Titled "TMJ TREATMENT DEVICE WITH ADAPTIVE CIRCUIT"
📈 PositiveBenzinga•Nov 5, 2025, 08:58 PM
Tivic Health Systems Completes Entolimod Cell Line Verification, Advancing CGMP In Preparation For Biologics License Application
📈 PositiveBenzinga•Sep 10, 2025, 12:41 PM
Tivic Receives Two Investigational New Drug Applications For Entolimod For Acute Radiation Syndrome And Advanced Cancers
📈 PositiveBenzinga•Aug 20, 2025, 12:33 PM
Tivic Health Sales Drop 39 Percent
📉 NegativeThe Motley Fool•Aug 14, 2025, 08:20 PM
Frequently Asked Questions about TIVC
What is TIVC's current stock price?
Tivic Health Systems, Inc. (TIVC) is currently trading at $1.74 per share. The stock has moved -7.94% today.
What is the analyst price target for TIVC?
No analyst price targets are currently available for this stock.
What sector is Tivic Health Systems, Inc. in?
Tivic Health Systems, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is TIVC's market cap?
Tivic Health Systems, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does TIVC pay dividends?
No, Tivic Health Systems, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBJDX
Bluejay Diagnostics, Inc.
$0.80
Mkt Cap: $0.0B
ELAB
PMGC Holdings Inc.
$2.26
Mkt Cap: $0.0B
MLEC
Moolec Science S.A.
$0.33
Mkt Cap: $0.0B
NCEL
NewcelX Ltd.
$2.60
Mkt Cap: $0.0B
NKGN
NKGen Biotech, Inc. Common Stock
$0.05
Mkt Cap: $0.0B
PRFX
PainReform Ltd.
$0.88
Mkt Cap: $0.0B
UPC
Universe Pharmaceuticals Inc.
$3.73
Mkt Cap: $0.0B
VRAX
Virax Biolabs Group Limited
$0.39
Mkt Cap: $0.0B
VTAK
Catheter Precision, Inc.
$1.98
Mkt Cap: $0.0B
WINT
Windtree Therapeutics, Inc.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to TIVC for comparison